Retail Associate who loves to explore her great city of Chicago!
"I still try to avoid my triggers but my disease is so much better controlled. I would tell anyone who is at their wits end with severe asthma to consider BT. It’s been a game changer for me."
My Life Prior to BT:
I’ve had allergic asthma since I was a child and it was always severe. Growing up I was unable to do so many of the normal things kids do. I was always the one sitting on the sidelines and not playing sports or swimming or running around like kids are suppose too. I always failed gym class. People assume when you are not doing stuff that you are just being lazy.
I tried hard to avoid my triggers but there were many. I couldn’t be near animals, dust, pollen, or outside if the temps were high. I was not able to really exercise because I got short of breath quickly. We tried many medications. I was on albuterol, Advair™, Singulair™, Symbicort™, Qvar™, DuoNeb™ and prednisone. I would use my inhaler every few minutes. It would be empty in a week.
The year before I had BT was the worst my severe asthma had ever been. I was in the hospital every other week. There were too many ER trips to count. I couldn’t work and I missed out on social events. I was really just living to breathe.
Believe it or not, I didn’t even have a pulmonologist. My primary care doctor was managing my severe asthma, but then finally told me that I had to see a specialist. That’s when I found Dr. Hogarth and I first heard about Bronchial Thermoplasty (BT). I will be honest with you, I was not on board right away. I was like “no way, I am so afraid of surgery!” But he explained BT is not a surgery but a series of procedures using a bronchoscope. I decided to think about it, but soon realized this was my only option because the medications were not doing to job.
My Life Today:
The three procedures went well for me. I went home the same day. I did have flare ups after each procedure, but it was no worse than what I had already been dealing with.
I started to see the big improvements in my severe asthma. It was gradual and started with little things. I would go grocery shopping and I wouldn’t have to sit down and rest in the middle of it. I noticed I wasn’t getting as short of breath all the time. Now it’s been over a year and the difference in my asthma control is dramatic.
With my severe asthma under control, I feel like I have my life back. I went back to work as a retail associate and I never miss work because of my disease. It feels so great to have a job! I can exercise now too without being hindered by severe asthma. I love to go walking and explore the city. Before, just walking around the grocery store was a challenge and now I can walk around my city.
Since my BT procedure, I have not been hospitalized nor had any ER trips for my asthma. I am just living my life now on my terms without being limited by severe asthma.
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
Brief Statement of Relevant Indications for Use, Contraindications, Warnings, and Adverse Events: The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common side effect of BT is an expected transient increase in the frequency and worsening of respiratory-related symptoms. ENDO-551804-AA
As with any procedure, there are risks, and individual results may vary. The most common adverse event of BT is a temporary worsening of respiratory-related symptoms. These events typically occur within one day of the BT procedure and usually resolve within a week with standard care. There is a small risk (3.4% per procedure) that symptoms may require hospitalization.1
- Castro M, et al, for the AIR2 Trial Study Group. Am J Respir Crit Care Med. 2010;181:116-124.